BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation

Lignende værker

• Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts
  af: Bozec, A, et al.
  Udgivet: (2007)
• Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours
  af: Beloueche-Babari, M, et al.
  Udgivet: (2015)
• A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
  af: Nokihara, Hiroshi, et al.
  Udgivet: (2012)
• ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
  af: Ryan, A J, et al.
  Udgivet: (2005)
• Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
  af: Yoshikawa, D, et al.
  Udgivet: (2009)